CYP19A1 and breast carcinoma: Much like MPD, MRI-FGT has been shown to be associated with breast cancer risk6, and sensitive to endogenous (e.g., menopause) and exogenous (e.g., tamoxifen, aromatase inhibitors) hormonal exposures7–9.